Supriya Lifescience Ltd
BSE:543434
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supriya Lifescience Ltd
BSE:543434
|
IN |
|
Jefferies Financial Group Inc
NYSE:JEF
|
US |
|
EVI Industries Inc
F:2YE
|
US |
|
F
|
F5 Inc
DUS:FFV
|
US |
|
Dian Swastatika Sentosa Tbk PT
IDX:DSSA
|
ID |
Wall St Price Targets
SUPRIYA Price Targets Summary
Supriya Lifescience Ltd
According to Wall Street analysts, the average 1-year price target for
SUPRIYA is 867 INR with a low forecast of 858.5 INR and a high forecast of 892.5 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUPRIYA's stock price target?
Price Target
867
INR
According to Wall Street analysts, the average 1-year price target for
SUPRIYA is 867 INR with a low forecast of 858.5 INR and a high forecast of 892.5 INR.
What is the Revenue forecast for Supriya Lifescience Ltd?
Projected CAGR
24%
Over the last 6 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 24%.
What is the Operating Income forecast for Supriya Lifescience Ltd?
Projected CAGR
21%
Over the last 6 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Supriya Lifescience Ltd?
Projected CAGR
21%
Over the last 6 years, the compound annual growth rate for Net Income has been 30%. The projected CAGR for the next 3 years is 21%.